---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-018753"
form_type: "8-K"
ticker: "MNPR"
cik: "0001645469"
company_name: "Monopar Therapeutics"
filed_at: "2023-06-28T23:59:59+00:00"
generated_at: "2026-06-13T15:32:54.089189+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Monopar Therapeutics stockholders elect six directors and ratify BPM LLP as auditor at 2023 annual meeting

## Summary
- All six director nominees elected with >8.7M for votes each; broker non-votes ~1.65M.
- Ratification of BPM LLP as independent auditor passed with 10,529,760 for, 3,071 against.
- Total shares represented 10,561,932 out of 13,222,055 entitled, ~80% turnout.
- No other matters were submitted to a vote at the meeting.
- Directors include Starr, Robinson, Brown, Anderson, Klausner, Tsuchimoto.

## SEC filing metadata
- accession: 0001437749-23-018753
- form_type: 8-K
- ticker: MNPR
- cik: 0001645469
- company_name: Monopar Therapeutics
- filed_at: 2023-06-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645469/000143774923018753/0001437749-23-018753-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645469/000143774923018753/mnpr20230627_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-018753
- JSON: https://secwatch.observer/filing/0001437749-23-018753.json
- Plain text: https://secwatch.observer/filing/0001437749-23-018753.txt

## Key facts
- Shareholder Votes
  Monopar Therapeutics shareholders approved Ratification of selection of BPM LLP as independent registered public accounting firm for year ending December 31, 2023 at the 2023-06-27 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-27
  source text: Proposal 2 – Ratification of Selection of Independent Registered Public Accounting Firm The voting results with respect to the proposal to ratify the selection of BPM LLP to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2023, were as follows: For Against Abstain Broker Non- Votes 10,529,760.056 3,071.000 29,101.000 N/A Accordingly, the Company’s stockholders ratified the selection of BPM LLP to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1645469/000143774923018753/0001437749-23-018753-index.htm
- Shareholder Votes
  Monopar Therapeutics shareholders approved Election of six directors at the 2023-06-27 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-27
  source text: Proposal 1 – Election of Directors At the Annual Meeting, the voting results with respect to the proposal for the election of directors, included in the Company’s Proxy Statement on Schedule 14A for the Annual Meeting, were as follows: Director For Withheld Broker Non- Votes Christopher M. Starr, Ph.D. 8,821,107.056 89,311.000 1,651,514.000 Chandler D. Robinson, MD MBA MSc 8,824,034.056 86,384.000 1,651,514.000 Michael J. Brown, MSc 8,822,931.056 87,487.000 1,651,514.000 Raymond W. Anderson, MBA 8,822,724.056 87,694.000 1,651,514.000 Arthur J. Klausner, MBA 8,785,520.056 124,898.000 1,651,514.000 Kim R. Tsuchimoto 8,820,687.056 89,731.000 1,651,514.000 Accordingly, each of the foregoing persons was elected as a director at the Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1645469/000143774923018753/0001437749-23-018753-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.